120 related articles for article (PubMed ID: 32559816)
1. KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral-driven sarcomagenesis.
Santarelli R; Arteni AMB; Gilardini Montani MS; Romeo MA; Gaeta A; Gonnella R; Faggioni A; Cirone M
Int J Cancer; 2020 Dec; 147(12):3500-3510. PubMed ID: 32559816
[TBL] [Abstract][Full Text] [Related]
2. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.
Gasperini P; Espigol-Frigole G; McCormick PJ; Salvucci O; Maric D; Uldrick TS; Polizzotto MN; Yarchoan R; Tosato G
Cancer Res; 2012 Mar; 72(5):1157-69. PubMed ID: 22237624
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
5. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.
Cheng F; Pekkonen P; Laurinavicius S; Sugiyama N; Henderson S; Günther T; Rantanen V; Kaivanto E; Aavikko M; Sarek G; Hautaniemi S; Biberfeld P; Aaltonen L; Grundhoff A; Boshoff C; Alitalo K; Lehti K; Ojala PM
Cell Host Microbe; 2011 Dec; 10(6):577-90. PubMed ID: 22177562
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
7. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
8. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
11. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
12. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
14. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.
Cavallin LE; Ma Q; Naipauer J; Gupta S; Kurian M; Locatelli P; Romanelli P; Nadji M; Goldschmidt-Clermont PJ; Mesri EA
PLoS Pathog; 2018 Jul; 14(7):e1007175. PubMed ID: 29985958
[TBL] [Abstract][Full Text] [Related]
15. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
16. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
Montaner S
Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
[TBL] [Abstract][Full Text] [Related]
17. The Kaposi's sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis.
Naipauer J; Mesri EA
Trends Mol Med; 2023 Mar; 29(3):188-200. PubMed ID: 36635149
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells.
Ye FC; Zhou FC; Nithianantham S; Chandran B; Yu XL; Weinberg A; Gao SJ
J Virol; 2013 Jun; 87(11):6326-35. PubMed ID: 23536671
[TBL] [Abstract][Full Text] [Related]
19. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.
Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z
Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574
[TBL] [Abstract][Full Text] [Related]
20. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
